Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
NCT01237288
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hypophosphatemic Rickets
Interventions
DRUG:
Z-521
Sponsor
Zeria Pharmaceutical